Green Alpha Advisors’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195K | Sell |
78,994
-4,473
| -5% | -$11K | 0.19% | 94 |
|
|
2025
Q1 | $166K | Buy |
83,467
+19,061
| +30% | +$37.9K | 0.18% | 97 |
|
|
2024
Q4 | $188K | Buy |
+64,406
| New | +$188K | 0.15% | 128 |
|
|
2024
Q3 | – | Sell |
-26,245
| Closed | -$135K | – | 143 |
|
|
2024
Q2 | $135K | Sell |
26,245
-7,493
| -22% | -$38.5K | 0.11% | 127 |
|
|
2024
Q1 | $236K | Buy |
33,738
+4,200
| +14% | +$29.4K | 0.17% | 128 |
|
|
2023
Q4 | $262K | Sell |
29,538
-8,277
| -22% | -$73.3K | 0.19% | 138 |
|
|
2023
Q3 | $361K | Buy |
37,815
+25,429
| +205% | +$243K | 0.28% | 115 |
|
|
2023
Q2 | $181K | Buy |
+12,386
| New | +$181K | 0.12% | 138 |
|